• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项多发性硬化症临床试验中扩展残疾状态量表(EDSS)和功能系统(FS)的评分者间变异性。加拿大合作多发性硬化症研究组。

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.

作者信息

Noseworthy J H, Vandervoort M K, Wong C J, Ebers G C

机构信息

Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada.

出版信息

Neurology. 1990 Jun;40(6):971-5. doi: 10.1212/wnl.40.6.971.

DOI:10.1212/wnl.40.6.971
PMID:2189084
Abstract

We describe the interrater variability in the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. Two physicians blinded to their previous assessments and to each other's scores consecutively examined 168 patients (545 paired examinations). Perfect agreement on the assignment of the disability scores ranged from 48% (cerebellar functional group) to 69% (EDSS and pyramidal functional group). Only 31% to 62% of this agreement occurred independently of that expected by chance (kappa). With the exception of the cerebellar and sensory functional groups, agreement within 1 step occurred in at least 92% of cases. These findings suggest that differences of a single step on these scales may not reflect an important functional change. We recommend that at least a 2-step change (1.0 point on the EDSS and 2 points on the FS) is needed to be confident of an important change in the degree of disability or response to treatment in this disease.

摘要

我们描述了在一项多发性硬化症临床试验中,扩展残疾状态量表(EDSS)和功能系统(FS)的评分者间变异性。两名对彼此先前评估及评分不知情的医生,对168名患者进行了连续检查(共545次配对检查)。残疾评分分配的完全一致性范围从48%(小脑功能组)到69%(EDSS和锥体功能组)。这种一致性中只有31%至62%是独立于偶然预期(kappa值)的。除小脑和感觉功能组外,至少92%的病例在1个等级内达成一致。这些发现表明,这些量表上1个等级的差异可能并不反映重要的功能变化。我们建议,要确信该疾病的残疾程度或治疗反应有重要变化,至少需要2个等级的变化(EDSS上1.0分,FS上2分)。

相似文献

1
Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.一项多发性硬化症临床试验中扩展残疾状态量表(EDSS)和功能系统(FS)的评分者间变异性。加拿大合作多发性硬化症研究组。
Neurology. 1990 Jun;40(6):971-5. doi: 10.1212/wnl.40.6.971.
2
Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group.使用Kurtzke扩展残疾状态量表(EDSS)1.0至3.5级的评分者间和评分者内一致性。多发性硬化症协作研究组。
Neurology. 1992 Apr;42(4):859-63. doi: 10.1212/wnl.42.4.859.
3
Self-administered Expanded Disability Status Scale with functional system scores correlates well with a physician-administered test.自我管理的扩展残疾状态量表及其功能系统评分与医生实施的测试相关性良好。
Mult Scler. 2001 Jun;7(3):201-6. doi: 10.1177/135245850100700311.
4
Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis.实现低成本、家庭式、远程医疗支持的多发性硬化症残疾评估。
Mult Scler. 2019 Oct;25(11):1526-1534. doi: 10.1177/1352458518793527. Epub 2018 Aug 24.
5
Observer disagreement in rating neurologic impairment in multiple sclerosis: facts and consequences.多发性硬化症神经功能缺损评分中的观察者分歧:事实与后果
Eur Neurol. 1991;31(2):117-9. doi: 10.1159/000116658.
6
The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
Lancet. 1991 Feb 23;337(8739):441-6.
7
Functional system scores provide a window into disease activity occurring during a multiple sclerosis treatment trial.功能系统评分提供了一个了解多发性硬化症治疗试验期间疾病活动情况的窗口。
Neurol Res. 2011 Jun;33(5):549-52. doi: 10.1179/1743132810Y.0000000017.
8
Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.多发性硬化症临床试验的结果指标:扩展残疾状态量表和多发性硬化症功能综合评分的相对测量精度
Mult Scler. 2004 Feb;10(1):41-6. doi: 10.1191/1352458504ms983oa.
9
Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.Kurtkze 扩展残疾状况量表与功能独立性测量的比较:多发性硬化症相关残疾的测量。
Disabil Rehabil. 2013;35(22):1877-84. doi: 10.3109/09638288.2013.766269. Epub 2013 Apr 19.
10
Walking function in clinical monitoring of multiple sclerosis by telemedicine.通过远程医疗对多发性硬化症进行临床监测时的行走功能
J Neurol. 2015 Jul;262(7):1706-13. doi: 10.1007/s00415-015-7764-x. Epub 2015 May 10.

引用本文的文献

1
Biomarkers of Progression Independent of Relapse Activity-Can We Actually Measure It Yet?独立于复发活动的疾病进展生物标志物——我们真的能够对其进行测量了吗?
Int J Mol Sci. 2025 May 14;26(10):4704. doi: 10.3390/ijms26104704.
2
Advancements in eye movement measurement technologies for assessing neurodegenerative diseases.用于评估神经退行性疾病的眼动测量技术进展。
Front Digit Health. 2024 Jul 4;6:1423790. doi: 10.3389/fdgth.2024.1423790. eCollection 2024.
3
Cost and Quality of Life of Disability Progression in Multiple Sclerosis Beyond EDSS: Impact of Cognition, Fatigue, and Limb Impairment.
多发性硬化症中超出扩展残疾状态量表的残疾进展的成本与生活质量:认知、疲劳和肢体损伤的影响
Pharmacoecon Open. 2024 Sep;8(5):665-678. doi: 10.1007/s41669-024-00501-x. Epub 2024 Jul 1.
4
Testing the Validity and Reliability of a Standardized Virtual Examination for Concussion.测试一种标准化脑震荡虚拟检查的有效性和可靠性。
Neurol Clin Pract. 2024 Oct;14(5):e200328. doi: 10.1212/CPJ.0000000000200328. Epub 2024 Jun 14.
5
A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis.一项关于阿仑单抗在真实世界多发性硬化症患者队列中疗效的为期五年的前瞻性单中心观察性研究。
Front Neurol. 2023 Sep 21;14:1265354. doi: 10.3389/fneur.2023.1265354. eCollection 2023.
6
Innovative multidimensional gait evaluation using IMU in multiple sclerosis: introducing the semiogram.在多发性硬化症中使用惯性测量单元进行创新的多维步态评估:引入半程图。
Front Neurol. 2023 Sep 15;14:1237162. doi: 10.3389/fneur.2023.1237162. eCollection 2023.
7
Wearable Sensor Technologies to Assess Motor Functions in People With Multiple Sclerosis: Systematic Scoping Review and Perspective.可穿戴传感器技术评估多发性硬化症患者的运动功能:系统综述和展望。
J Med Internet Res. 2023 Jul 27;25:e44428. doi: 10.2196/44428.
8
Multiple Sclerosis Disease Activity and Disability Following Cessation of Fingolimod for Pregnancy.多发性硬化症患者停止使用芬戈莫德后疾病活动和残疾的情况。
Neurol Neuroimmunol Neuroinflamm. 2023 May 22;10(4). doi: 10.1212/NXI.0000000000200110. Print 2023 Jul.
9
The role of autoimmune antibodies to predict secondary autoimmunity in patients with relapsing-remitting multiple sclerosis treated with alemtuzumab: A nationwide prospective survey.自身免疫抗体在预测接受阿仑单抗治疗的复发缓解型多发性硬化患者继发自身免疫中的作用:一项全国性前瞻性调查。
Front Neurol. 2023 Mar 16;14:1137665. doi: 10.3389/fneur.2023.1137665. eCollection 2023.
10
Subtypes of relapsing-remitting multiple sclerosis identified by network analysis.通过网络分析确定的复发缓解型多发性硬化症亚型。
Front Digit Health. 2023 Jan 11;4:1063264. doi: 10.3389/fdgth.2022.1063264. eCollection 2022.